|
OMIM |
Link |
Information gain |
01 |
|
CRC
|
[NCBI]
|
0.0152034
|
|
|
KLK3
|
[NCBI]
|
0.00714998
|
|
|
IS1
|
[NCBI]
|
0.00157957
|
|
|
panic disorder 2
|
[NCBI]
|
0.00114987
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.00109455
|
|
|
RA
|
[NCBI]
|
0.000983515
|
|
|
AFP
|
[NCBI]
|
0.00082972
|
|
|
CD
|
[NCBI]
|
0.000756119
|
|
|
CNA1
|
[NCBI]
|
0.000720912
|
|
|
iminoglycinuria
|
[NCBI]
|
0.000576422
|
|
|
PAND1
|
[NCBI]
|
0.000453401
|
|
|
chiari malformation type i
|
[NCBI]
|
0.000398996
|
|
|
SLE
|
[NCBI]
|
0.000326856
|
|
|
APC
|
[NCBI]
|
0.000306219
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000302292
|
|
|
histidinemia
|
[NCBI]
|
0.000257457
|
|
|
cystathioninuria
|
[NCBI]
|
0.000186173
|
|
|
MDD
|
[NCBI]
|
0.000151463
|
|
|
MAFD6
|
[NCBI]
|
0.000150188
|
|
|
CHNG2
|
[NCBI]
|
0.000116139
|
|
|
biotinidase deficiency
|
[NCBI]
|
0.00011356
|
|
|
IDDM
|
[NCBI]
|
9.94356e-05
|
|
|
VEGF
|
[NCBI]
|
9.62982e-05
|
|
|
EGF
|
[NCBI]
|
9.56988e-05
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
8.11039e-05
|
|
|
TSD
|
[NCBI]
|
7.98112e-05
|
|
|
CEACAM5
|
[NCBI]
|
7.5893e-05
|
|
|
hartnup disorder
|
[NCBI]
|
7.56752e-05
|
|
|
CJD
|
[NCBI]
|
7.14438e-05
|
|
|
ACPP
|
[NCBI]
|
6.28128e-05
|
|
|
G6PD
|
[NCBI]
|
6.2043e-05
|
|
|
AD
|
[NCBI]
|
5.70956e-05
|
|
|
hydroxyprolinemia
|
[NCBI]
|
5.25135e-05
|
|
|
costello syndrome
|
[NCBI]
|
4.79711e-05
|
|
|
HFE
|
[NCBI]
|
4.38432e-05
|
|
|
sarcosinemia
|
[NCBI]
|
4.37329e-05
|
|
|
LGMD2F
|
[NCBI]
|
4.37329e-05
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
4.0536e-05
|
|
|
PRL
|
[NCBI]
|
3.91115e-05
|
|
|
phenylketonuria
|
[NCBI]
|
3.88156e-05
|
|
|
MAT1A
|
[NCBI]
|
3.75297e-05
|
|
|
PD
|
[NCBI]
|
3.6579e-05
|
|
|
neuroblastoma
|
[NCBI]
|
3.5633e-05
|
|
|
galactosemia
|
[NCBI]
|
3.49288e-05
|
|
|
GRA
|
[NCBI]
|
3.42427e-05
|
|
|
PCNA
|
[NCBI]
|
3.40037e-05
|
|
|
LGMD2E
|
[NCBI]
|
3.3396e-05
|
|
|
CTLN2
|
[NCBI]
|
3.3396e-05
|
|
|
schwannomatosis
|
[NCBI]
|
3.3396e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
3.1547e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
2.9881e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
2.83674e-05
|
|
|
TWISTNB
|
[NCBI]
|
2.75189e-05
|
|
|
FMF
|
[NCBI]
|
2.70409e-05
|
|
|
PG
|
[NCBI]
|
2.69552e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
2.57353e-05
|
|
|
BDNF
|
[NCBI]
|
2.4325e-05
|
|
|
CRH
|
[NCBI]
|
2.38937e-05
|
|
|
PHA
|
[NCBI]
|
2.34342e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
2.34342e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
2.2964e-05
|
|
|
ACHE
|
[NCBI]
|
2.26353e-05
|
|
|
HRPT1
|
[NCBI]
|
2.14571e-05
|
|
|
PCLD
|
[NCBI]
|
2.14571e-05
|
|
|
KTCN1
|
[NCBI]
|
2.05601e-05
|
|
|
HBD
|
[NCBI]
|
2.00064e-05
|
|
|
COH1
|
[NCBI]
|
1.97416e-05
|
|
|
ETM1
|
[NCBI]
|
1.97158e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
1.89192e-05
|
|
|
MPO
|
[NCBI]
|
1.83195e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
1.81661e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
1.74526e-05
|
|
|
SLOS
|
[NCBI]
|
1.69388e-05
|
|
|
lung cancer
|
[NCBI]
|
1.61318e-05
|
|
|
BRCA1
|
[NCBI]
|
1.49744e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.49346e-05
|
|
|
FOXE1
|
[NCBI]
|
1.40987e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
1.38436e-05
|
|
|
PTH
|
[NCBI]
|
1.35739e-05
|
|
|
ADHD
|
[NCBI]
|
1.35252e-05
|
|
|
SGCA
|
[NCBI]
|
1.3359e-05
|
|
|
LGMD2C
|
[NCBI]
|
1.33336e-05
|
|
|
ALD
|
[NCBI]
|
1.28612e-05
|
|
|
PTS
|
[NCBI]
|
1.27073e-05
|
|
|
CVS
|
[NCBI]
|
1.23768e-05
|
|
|
CMH
|
[NCBI]
|
1.23201e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
1.21257e-05
|
|
|
GJB6
|
[NCBI]
|
1.18569e-05
|
|
|
GFER
|
[NCBI]
|
1.11235e-05
|
|
|
LDHB
|
[NCBI]
|
1.06859e-05
|
|
|
COH1
|
[NCBI]
|
1.06827e-05
|
|
|
lactase persistence
|
[NCBI]
|
1.06827e-05
|
|
|
APOE
|
[NCBI]
|
1.01091e-05
|
|
|
melanoma, uveal
|
[NCBI]
|
9.92968e-06
|
|
|
DPYD
|
[NCBI]
|
9.73052e-06
|
|
|
POAG
|
[NCBI]
|
9.57382e-06
|
|
|
ACADM
|
[NCBI]
|
9.50184e-06
|
|
|
F3
|
[NCBI]
|
9.09623e-06
|
|
|
LTA
|
[NCBI]
|
8.6389e-06
|
|
|
ACADS
|
[NCBI]
|
8.6389e-06
|
|
|
HBB
|
[NCBI]
|
8.39116e-06
|
|
|
SCS
|
[NCBI]
|
7.97534e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
7.85993e-06
|
|
|
ENG
|
[NCBI]
|
7.7473e-06
|
|
|
HBG2
|
[NCBI]
|
7.30446e-06
|
|
|
HS
|
[NCBI]
|
6.99824e-06
|
|
|
VDR
|
[NCBI]
|
6.82821e-06
|
|
|
GALT
|
[NCBI]
|
6.80504e-06
|
|
|
MHS1
|
[NCBI]
|
6.6315e-06
|
|
|
maple syrup urine disease
|
[NCBI]
|
6.6315e-06
|
|
|
PSEN2
|
[NCBI]
|
6.44213e-06
|
|
|
CFTR
|
[NCBI]
|
5.94252e-06
|
|
|
hurler syndrome
|
[NCBI]
|
5.70629e-06
|
|
|
GPT
|
[NCBI]
|
5.64945e-06
|
|
|
MTHFR
|
[NCBI]
|
4.63448e-06
|
|
|
PI
|
[NCBI]
|
4.56469e-06
|
|
|
GBA
|
[NCBI]
|
4.26332e-06
|
|
|
porphyria variegata
|
[NCBI]
|
4.17782e-06
|
|
|
gaucher disease, type i
|
[NCBI]
|
4.17782e-06
|
|
|
homocystinuria
|
[NCBI]
|
4.01989e-06
|
|
|
MEN2A
|
[NCBI]
|
4.01262e-06
|
|
|
MFS
|
[NCBI]
|
3.87398e-06
|
|
|
LPI
|
[NCBI]
|
3.85255e-06
|
|
|
AIRE
|
[NCBI]
|
3.79246e-06
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
3.69745e-06
|
|
|
PJS
|
[NCBI]
|
3.57566e-06
|
|
|
LDLR
|
[NCBI]
|
3.47552e-06
|
|
|
PCI
|
[NCBI]
|
3.30311e-06
|
|
|
ADA
|
[NCBI]
|
3.29637e-06
|
|
|
AVSD
|
[NCBI]
|
3.26049e-06
|
|
|
BWS
|
[NCBI]
|
3.00431e-06
|
|
|
ESD
|
[NCBI]
|
2.78398e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
2.73896e-06
|
|
|
SHBG
|
[NCBI]
|
2.71991e-06
|
|
|
HBA2
|
[NCBI]
|
2.6601e-06
|
|
|
breast cancer
|
[NCBI]
|
2.61866e-06
|
|
|
SPP1
|
[NCBI]
|
2.54822e-06
|
|
|
BRCA2
|
[NCBI]
|
2.54165e-06
|
|
|
GAPDH
|
[NCBI]
|
1.93253e-06
|
|
|
wilson disease
|
[NCBI]
|
1.78547e-06
|
|
|
PSEN1
|
[NCBI]
|
1.73606e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
1.691e-06
|
|
|
TF
|
[NCBI]
|
1.65529e-06
|
|
|
TTR
|
[NCBI]
|
1.45301e-06
|
|
|
GJB2
|
[NCBI]
|
1.33181e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.29321e-06
|
|
|
DMD
|
[NCBI]
|
1.19e-06
|
|
|
APS1
|
[NCBI]
|
1.15127e-06
|
|
|
fabry disease
|
[NCBI]
|
1.08417e-06
|
|
|
GTS
|
[NCBI]
|
9.02755e-07
|
|
|
CD
|
[NCBI]
|
8.97664e-07
|
|
|
FMR1
|
[NCBI]
|
8.92642e-07
|
|
|
ALB
|
[NCBI]
|
8.4465e-07
|
|
|
HBA1
|
[NCBI]
|
4.03926e-07
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.84838e-07
|
|
|
TS
|
[NCBI]
|
2.73501e-07
|
|
|
TG
|
[NCBI]
|
1.68553e-07
|
|
|
CP
|
[NCBI]
|
1.43809e-07
|
|
|
MBL2
|
[NCBI]
|
1.05867e-07
|
|
|
APOB
|
[NCBI]
|
6.86103e-08
|
|
|
TPO
|
[NCBI]
|
3.92389e-08
|
|
|
CF
|
[NCBI]
|
1.77552e-08
|
|
|
LAM
|
[NCBI]
|
1.75504e-08
|
|
|
PCD
|
[NCBI]
|
1.75504e-08
|
|